In this dynamic video, expert faculty discuss the prevention and acute treatment of migraine.
Slides on advances in prevention and acute treatment of migraine
My reflection on how far we’ve come in improving the treatment of acute and chronic migraine, from triptans and beta-blockers to small molecules and monoclonal antibodies that target CGRP.
My take on real-world successes, challenges, and ongoing questions on the use of monoclonal antibodies that target CGRP for migraine prophylaxis.
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.